Weeks after the National Agency for Food and Drug Administration and Control approved the use of chloroquine for the clinical trial treatment of the coronavirus disease, states affected by the wide-spreading virus have yet to signify interest to embrace the initiative.
The Director General of the agency, Prof Mojisola Adeyeye, on Friday said that only Lagos State, which has 109 confirmed cases, the highest in the country, had signified interest in using the drug for clinical trial to find treatment for the virus.
The other states that have recorded cases are Osun (22 cases); Oyo (eight); Akwa Ibom (five); Ogun (four); Edo (seven); Kaduna (four); Bauchi (three); Enugu (two); Ekiti (two); Rivers (one); Benue (one) and Ondo (one), which was confirmed on Friday evening, and the Federal Capital Territory with 41 cases.
As of Friday evening, the number of confirmed cases in Nigeria stood at 210, out of which 25 patients had been discharged in Lagos and Ekiti states, while four deaths have so far been recorded. The two new deaths confirmed on Friday were in Lagos and Edo states. Across the world, the number of cases had risen to 1,093,887 cases, out of which 228,037 had recovered and 58,752 had died.
NAFDAC, which approves medicines meant for clinical trials, had on March 20 approved the use of chloroquine for clinical trial, warning however that the approval was not for the drug to be used as treatment for the virus.
The DG had said, “NAFDAC is not approving chloroquine as a product that can be used for coronavirus because there is no submission to us for registration, but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials. Therefore, the medicine is being approved just for the clinical trials.”
NAFDAC’s approval came about three years after the Federal Government in 2017 banned the use of chloroquine and artemisinin monotherapy used in the treatment of malaria in the country.
Source: News update